Clinical Trials Directory

Trials / Completed

CompletedNCT03189290

Study of the QUadratus Lumborum Bloc in Total Hip ARthroplasty: Efficacy and Safety

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

The purpose of this prospective research study is to determine the best way to manage post-operative pain after a total hip arthroplasty. Currently, there is no standard of care for managing post-operative pain in these patients. The quadratus lumborum block (QLB) first described by Blanco in 2007, is a promising technique in this indication: recently, there is a growing evidence for the use of the QLB as an alternative technique for pain management after hip surgery.

Detailed description

A sample size of 100 patients (50 per group) was calculated based on 20% reduction in morphine consumption with 0.05% significance and a power of 0.8. After ethical committee approval, eligible patients scheduled to have a fast-track total hip arthroplasty are screened during preoperative evaluation clinic. Informed written consent will be obtained from all patients during pre-anesthesia visit the day before surgery (J-1). Consenting patients will be randomized the day of surgery (J0) to undergo QLB with ropivacaine ("ropivacaine group") or normal saline ("saline group"). Before general anesthesia, all patients will have a needle-insertion posterior to the quadratus lumborum muscle avec injection of either ropivacaine in the "ropivacaine group" or normal saline in the "saline group". After general anesthesia induction, dexamethasone and ketamine will be given to all patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREposterior Quadratus Lumborum Block (QLB)Procedure (experimental): ultrasound guided posterior Quadratus Lumborum Block (QLB) Procedure (experimental): Sham Block

Timeline

Start date
2017-07-06
Primary completion
2018-09-10
Completion
2018-09-10
First posted
2017-06-16
Last updated
2019-04-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03189290. Inclusion in this directory is not an endorsement.